Report cover image

Global Rapid-dissolving Tablets Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 198 Pages
SKU # APRC20561401

Description

Summary

According to APO Research, The global Rapid-dissolving Tablets market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Rapid-dissolving Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Rapid-dissolving Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Rapid-dissolving Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Rapid-dissolving Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Rapid-dissolving Tablets include Bristol-Myers Squibb, Conquer, Otsuka, AstraZeneca, GSK, Pfizer, Eli Lilly and Company, Mylan and Merck, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Rapid-dissolving Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Rapid-dissolving Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Rapid-dissolving Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rapid-dissolving Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Rapid-dissolving Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Rapid-dissolving Tablets sales, projected growth trends, production technology, application and end-user industry.

Rapid-dissolving Tablets Segment by Company

Bristol-Myers Squibb
Conquer
Otsuka
AstraZeneca
GSK
Pfizer
Eli Lilly and Company
Mylan
Merck
Johnson and Johnson
Teva
Rapid-dissolving Tablets Segment by Type

Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Rapid-dissolving Tablets Segment by Application

CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
Rapid-dissolving Tablets Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rapid-dissolving Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rapid-dissolving Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rapid-dissolving Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Rapid-dissolving Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Rapid-dissolving Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rapid-dissolving Tablets sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Rapid-dissolving Tablets Market by Type
1.2.1 Global Rapid-dissolving Tablets Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Anti-Psychotics Drug
1.2.3 Anti-Epileptics Drug
1.2.4 Other
1.3 Rapid-dissolving Tablets Market by Application
1.3.1 Global Rapid-dissolving Tablets Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 CNS Diseases
1.3.3 Gastrointestinal Diseases
1.3.4 CVS Diseases
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Rapid-dissolving Tablets Market Dynamics
2.1 Rapid-dissolving Tablets Industry Trends
2.2 Rapid-dissolving Tablets Industry Drivers
2.3 Rapid-dissolving Tablets Industry Opportunities and Challenges
2.4 Rapid-dissolving Tablets Industry Restraints
3 Global Market Growth Prospects
3.1 Global Rapid-dissolving Tablets Revenue Estimates and Forecasts (2020-2031)
3.2 Global Rapid-dissolving Tablets Revenue by Region
3.2.1 Global Rapid-dissolving Tablets Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Rapid-dissolving Tablets Revenue by Region (2020-2025)
3.2.3 Global Rapid-dissolving Tablets Revenue by Region (2026-2031)
3.2.4 Global Rapid-dissolving Tablets Revenue Market Share by Region (2020-2031)
3.3 Global Rapid-dissolving Tablets Sales Estimates and Forecasts 2020-2031
3.4 Global Rapid-dissolving Tablets Sales by Region
3.4.1 Global Rapid-dissolving Tablets Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Rapid-dissolving Tablets Sales by Region (2020-2025)
3.4.3 Global Rapid-dissolving Tablets Sales by Region (2026-2031)
3.4.4 Global Rapid-dissolving Tablets Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Rapid-dissolving Tablets Revenue by Manufacturers
4.1.1 Global Rapid-dissolving Tablets Revenue by Manufacturers (2020-2025)
4.1.2 Global Rapid-dissolving Tablets Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Rapid-dissolving Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Rapid-dissolving Tablets Sales by Manufacturers
4.2.1 Global Rapid-dissolving Tablets Sales by Manufacturers (2020-2025)
4.2.2 Global Rapid-dissolving Tablets Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Rapid-dissolving Tablets Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Rapid-dissolving Tablets Sales Price by Manufacturers (2020-2025)
4.4 Global Rapid-dissolving Tablets Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Rapid-dissolving Tablets Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Rapid-dissolving Tablets Manufacturers, Product Type & Application
4.7 Global Rapid-dissolving Tablets Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Rapid-dissolving Tablets Market CR5 and HHI
4.8.2 2024 Rapid-dissolving Tablets Tier 1, Tier 2, and Tier 3
5 Rapid-dissolving Tablets Market by Type
5.1 Global Rapid-dissolving Tablets Revenue by Type
5.1.1 Global Rapid-dissolving Tablets Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Rapid-dissolving Tablets Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Rapid-dissolving Tablets Revenue Market Share by Type (2020-2031)
5.2 Global Rapid-dissolving Tablets Sales by Type
5.2.1 Global Rapid-dissolving Tablets Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Rapid-dissolving Tablets Sales by Type (2020-2031) & (k units)
5.2.3 Global Rapid-dissolving Tablets Sales Market Share by Type (2020-2031)
5.3 Global Rapid-dissolving Tablets Price by Type
6 Rapid-dissolving Tablets Market by Application
6.1 Global Rapid-dissolving Tablets Revenue by Application
6.1.1 Global Rapid-dissolving Tablets Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Rapid-dissolving Tablets Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Rapid-dissolving Tablets Revenue Market Share by Application (2020-2031)
6.2 Global Rapid-dissolving Tablets Sales by Application
6.2.1 Global Rapid-dissolving Tablets Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Rapid-dissolving Tablets Sales by Application (2020-2031) & (k units)
6.2.3 Global Rapid-dissolving Tablets Sales Market Share by Application (2020-2031)
6.3 Global Rapid-dissolving Tablets Price by Application
7 Company Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Comapny Information
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Bristol-Myers Squibb Rapid-dissolving Tablets Product Portfolio
7.1.5 Bristol-Myers Squibb Recent Developments
7.2 Conquer
7.2.1 Conquer Comapny Information
7.2.2 Conquer Business Overview
7.2.3 Conquer Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Conquer Rapid-dissolving Tablets Product Portfolio
7.2.5 Conquer Recent Developments
7.3 Otsuka
7.3.1 Otsuka Comapny Information
7.3.2 Otsuka Business Overview
7.3.3 Otsuka Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Otsuka Rapid-dissolving Tablets Product Portfolio
7.3.5 Otsuka Recent Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Comapny Information
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 AstraZeneca Rapid-dissolving Tablets Product Portfolio
7.4.5 AstraZeneca Recent Developments
7.5 GSK
7.5.1 GSK Comapny Information
7.5.2 GSK Business Overview
7.5.3 GSK Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 GSK Rapid-dissolving Tablets Product Portfolio
7.5.5 GSK Recent Developments
7.6 Pfizer
7.6.1 Pfizer Comapny Information
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Pfizer Rapid-dissolving Tablets Product Portfolio
7.6.5 Pfizer Recent Developments
7.7 Eli Lilly and Company
7.7.1 Eli Lilly and Company Comapny Information
7.7.2 Eli Lilly and Company Business Overview
7.7.3 Eli Lilly and Company Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Eli Lilly and Company Rapid-dissolving Tablets Product Portfolio
7.7.5 Eli Lilly and Company Recent Developments
7.8 Mylan
7.8.1 Mylan Comapny Information
7.8.2 Mylan Business Overview
7.8.3 Mylan Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Mylan Rapid-dissolving Tablets Product Portfolio
7.8.5 Mylan Recent Developments
7.9 Merck
7.9.1 Merck Comapny Information
7.9.2 Merck Business Overview
7.9.3 Merck Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Merck Rapid-dissolving Tablets Product Portfolio
7.9.5 Merck Recent Developments
7.10 Johnson and Johnson
7.10.1 Johnson and Johnson Comapny Information
7.10.2 Johnson and Johnson Business Overview
7.10.3 Johnson and Johnson Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Johnson and Johnson Rapid-dissolving Tablets Product Portfolio
7.10.5 Johnson and Johnson Recent Developments
7.11 Teva
7.11.1 Teva Comapny Information
7.11.2 Teva Business Overview
7.11.3 Teva Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Teva Rapid-dissolving Tablets Product Portfolio
7.11.5 Teva Recent Developments
8 North America
8.1 North America Rapid-dissolving Tablets Market Size by Type
8.1.1 North America Rapid-dissolving Tablets Revenue by Type (2020-2031)
8.1.2 North America Rapid-dissolving Tablets Sales by Type (2020-2031)
8.1.3 North America Rapid-dissolving Tablets Price by Type (2020-2031)
8.2 North America Rapid-dissolving Tablets Market Size by Application
8.2.1 North America Rapid-dissolving Tablets Revenue by Application (2020-2031)
8.2.2 North America Rapid-dissolving Tablets Sales by Application (2020-2031)
8.2.3 North America Rapid-dissolving Tablets Price by Application (2020-2031)
8.3 North America Rapid-dissolving Tablets Market Size by Country
8.3.1 North America Rapid-dissolving Tablets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Rapid-dissolving Tablets Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Rapid-dissolving Tablets Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Rapid-dissolving Tablets Market Size by Type
9.1.1 Europe Rapid-dissolving Tablets Revenue by Type (2020-2031)
9.1.2 Europe Rapid-dissolving Tablets Sales by Type (2020-2031)
9.1.3 Europe Rapid-dissolving Tablets Price by Type (2020-2031)
9.2 Europe Rapid-dissolving Tablets Market Size by Application
9.2.1 Europe Rapid-dissolving Tablets Revenue by Application (2020-2031)
9.2.2 Europe Rapid-dissolving Tablets Sales by Application (2020-2031)
9.2.3 Europe Rapid-dissolving Tablets Price by Application (2020-2031)
9.3 Europe Rapid-dissolving Tablets Market Size by Country
9.3.1 Europe Rapid-dissolving Tablets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Rapid-dissolving Tablets Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Rapid-dissolving Tablets Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Rapid-dissolving Tablets Market Size by Type
10.1.1 China Rapid-dissolving Tablets Revenue by Type (2020-2031)
10.1.2 China Rapid-dissolving Tablets Sales by Type (2020-2031)
10.1.3 China Rapid-dissolving Tablets Price by Type (2020-2031)
10.2 China Rapid-dissolving Tablets Market Size by Application
10.2.1 China Rapid-dissolving Tablets Revenue by Application (2020-2031)
10.2.2 China Rapid-dissolving Tablets Sales by Application (2020-2031)
10.2.3 China Rapid-dissolving Tablets Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Rapid-dissolving Tablets Market Size by Type
11.1.1 Asia Rapid-dissolving Tablets Revenue by Type (2020-2031)
11.1.2 Asia Rapid-dissolving Tablets Sales by Type (2020-2031)
11.1.3 Asia Rapid-dissolving Tablets Price by Type (2020-2031)
11.2 Asia Rapid-dissolving Tablets Market Size by Application
11.2.1 Asia Rapid-dissolving Tablets Revenue by Application (2020-2031)
11.2.2 Asia Rapid-dissolving Tablets Sales by Application (2020-2031)
11.2.3 Asia Rapid-dissolving Tablets Price by Application (2020-2031)
11.3 Asia Rapid-dissolving Tablets Market Size by Country
11.3.1 Asia Rapid-dissolving Tablets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Rapid-dissolving Tablets Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Rapid-dissolving Tablets Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Rapid-dissolving Tablets Market Size by Type
12.1.1 SAMEA Rapid-dissolving Tablets Revenue by Type (2020-2031)
12.1.2 SAMEA Rapid-dissolving Tablets Sales by Type (2020-2031)
12.1.3 SAMEA Rapid-dissolving Tablets Price by Type (2020-2031)
12.2 SAMEA Rapid-dissolving Tablets Market Size by Application
12.2.1 SAMEA Rapid-dissolving Tablets Revenue by Application (2020-2031)
12.2.2 SAMEA Rapid-dissolving Tablets Sales by Application (2020-2031)
12.2.3 SAMEA Rapid-dissolving Tablets Price by Application (2020-2031)
12.3 SAMEA Rapid-dissolving Tablets Market Size by Country
12.3.1 SAMEA Rapid-dissolving Tablets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Rapid-dissolving Tablets Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Rapid-dissolving Tablets Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Rapid-dissolving Tablets Value Chain Analysis
13.1.1 Rapid-dissolving Tablets Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Rapid-dissolving Tablets Production Mode & Process
13.2 Rapid-dissolving Tablets Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Rapid-dissolving Tablets Distributors
13.2.3 Rapid-dissolving Tablets Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.